Surescripts, LLC

Surescripts, LLC is a privately held health information network headquartered in Arlington, VA. Its core mission is to serve the nation through simpler, trusted health intelligence sharing, aiming to increase patient safety, lower costs, and ensure quality care. The company acts as a neutral intermediary, connecting virtually all electronic health records (EHRs), health systems, pharmacies, and pharmacy benefit managers (PBMs) across the United States.

Surescripts offers a comprehensive suite of solutions designed to streamline healthcare processes. Key offerings include electronic prescribing (e-prescribing) for both legend drugs and controlled substances, medication history services, and Real-Time Prescription Benefit and Price Intelligence, which provides patient-specific cost and coverage information at the point of care. The company also specializes in prior authorization automation, including its Intelligent Prior Authorization and Prior Authorization Portal, to reduce administrative burdens and accelerate patient access to therapy. These services cater to healthcare professionals, EHR vendors, health systems, pharmacies, PBMs, health plans, and life sciences companies.

In October 2024, TPG, a global alternative asset management firm, acquired a majority stake in Surescripts, with existing shareholders retaining minority interests, to further invest in technology and potential mergers and acquisitions. Frank Harvey serves as the Chief Executive Officer, and Laura Moran joined as President and Chief Commercial Officer in 2026. Surescripts continues to be a leading health intelligence network, reporting 30.5 billion health intelligence transactions in 2025 and one billion Real-Time Prescription Benefit responses. Recent efforts in 2026 have focused on expanding prior authorization automation and addressing patient roadblocks in prescription access.